BioCentury | Dec 7, 2009
Company News

OrthoMimetics, TiGenix deal

...TiGenix completed its previously announced acquisition of OrthoMimetics in a stock deal valued at €16 million...
...March 30, 2012, at an issuance price of €4.28 per share (see BioCentury, Nov. 23). OrthoMimetics Ltd....
BioCentury | Nov 23, 2009
Company News

OrthoMimetics, TiGenix deal

...TiGenix will acquire OrthoMimetics in a stock deal valued at €15.8 million ($23.6 million) based on...
...single symptomatic cartilage defects of the femoral condyle in the knee (see BioCentury, Oct. 12). OrthoMimetics Ltd....
Items per page:
1 - 2 of 2
BioCentury | Dec 7, 2009
Company News

OrthoMimetics, TiGenix deal

...TiGenix completed its previously announced acquisition of OrthoMimetics in a stock deal valued at €16 million...
...March 30, 2012, at an issuance price of €4.28 per share (see BioCentury, Nov. 23). OrthoMimetics Ltd....
BioCentury | Nov 23, 2009
Company News

OrthoMimetics, TiGenix deal

...TiGenix will acquire OrthoMimetics in a stock deal valued at €15.8 million ($23.6 million) based on...
...single symptomatic cartilage defects of the femoral condyle in the knee (see BioCentury, Oct. 12). OrthoMimetics Ltd....
Items per page:
1 - 2 of 2